General Interest

Towers Watson Reported Q4 Results, Issued Guidance

Published on Tue, 08/16/2011 - 09:22
By FNNO Staff in General Interest, TW, analysis, business, financial news, market, stock, trading, tw, News Update

The company sees Q1 EPS of $1.02 to $1.07, vs. consensus estimates of $1.06 per share, on revenues of $800 to $825 million, vs.

analysis, business, financial news, market, stock, trading, tw

Towers Watson (NYSE:TW) reported Q4 EPS of $1.06, ahead of consensus estimates of $1.03 per share. Revenues for the quarter rose 13.5% year-over-year to $851.3 million, vs. consensus estimates of $814.0 million.

By FNNO Staff
fnnonline@gmail.com

Saks Reports Narrower Q2 Loss, Revenue Rose 15.5% YoY (SKS)

Stephen I. Sadove, Chairman and Chief Executive Officer of the Company, noted, "Through the second quarter, our customers remained confident and continued to respond to our differentiated merchandise, service initiatives, and crea

business, finance, investing, market, news, opening, saks international, stock, store, times square, trading

Saks Incorporated (NYSE:SKS) reported Q2 loss of $0.05 versus a year ago loss of $0.21. Revenues rose 15.5% year-over-year to $670 million, better than consensus estimates of $663.84 million.

By FNNO Staff
fnnonline@gmail.com

Housing Starts Fall 1.5% in July

The Commerce Department said starts fell to a seasonally adjusted annual rate of 604,000 from a downwardly revised 613,000 rate in June.

business, commerce department, data, finance, housing, investing, market, news, real estate, stock, trading

In July, housing starts slipped 1.5%, according to data released Tuesday that reveal the negative impact on demand for new houses that comes from cheaper foreclosed homes, underwater mortgages, tight lending standards and high une

By FNNO Staff
fnnonline@gmail.com

JinkoSolar Holding Reported In Line Q2 EPS

The company sees Q3 revenues of $310 to $330 million, vs. consensus estimates of $343.13 million, with shipments of about 230 to 250 MW. For 2011, JinkoSolar sees revenues of $1.4 to $1.5 billion, vs. consensus estimates of $1.36

Mr.

business, earnings, eps, finance, investing, jinkosolar holding, market, news, revenue, second quarter, stock, trading

JinkoSolar Holding (NYSE:JKS) reported Q2 EPS of $1.38, in line with consensus estimates. Revenues for the quarter rose 152% year-over-year to $350.6 million, topping consensus estimates of $320.3 million.

By FNNO Staff
fnnonline@gmail.com

Nordstrom To Open Non-Traditional Store In New York City

Published on Tue, 08/16/2011 - 07:56
By FNNO Staff in General Interest, jwn, business, finance, investing, market, news, nordstrom, stock, trading, News Update

Furthermore, the new store will be less than 10% of the size of a typical Nordstrom location and all of its profits will be donated to charity.

Nordstrom (NYSE:JWN) has a potential upside of 18.6% based on a current price of $44.67 and an average consensus analyst price target of $53.

business, finance, investing, market, news, nordstrom, stock, trading

The New York Times reported that Nordstrom (NYSE:JWN) is finally opening a full-priced store in New York City, but the store won't be called Nordstrom, and it won't have the traditional feel or merchandise of one of the retailer's

By FNNO Staff
fnnonline@gmail.com

Johnson & Johnson's McNeil Rcalling Tylenol Cold Nighttime Gelcaps

Published on Mon, 08/15/2011 - 15:19
By FNNO Staff in General Interest, JNJ, business, finance, johnson & johnson, market, news, price, recall, share, stock, tylenol, News Update

This is not a consumer level recall and the risk of any adverse health effects related to the to the reason for the recall is unlikely.

business, finance, johnson & johnson, market, news, price, recall, share, stock, tylenol

Johnson & Johnson's McNeil Consumer Healthcare is voluntarily recalling, at the retail and wholesale level, certain lots of products containing Tylenol Cold-Multi Symptom Nighttime Rapid Release Gelcaps distributed in the U.S.

By FNNO Staff
fnnonline@gmail.com

Aurizon Mines confirms hiring George Paspalas as CEO

Published on Mon, 08/15/2011 - 13:48
By FNNO Staff in General Interest, AZK, business, FINANCE, Investing, Market, news, Stock, trading, In The News

The company confirmed that David Hall, who retired from his positions as President and CEO, will continue to serve the company as Chairman of the Board.

David Hall commented, "We are delighted to welcome George to the Aurizon team.

Aurizon Mines (AMEX:AZK) confirmed that George Paspalas has joined the company as its new President, CEO and member of the company's Board of Directors.

By FNNO Staff
fnnonline@gmail.com

Kratos Defense & Security Solutions Announced It Received A $10M Contract

Published on Mon, 08/15/2011 - 13:44
By FNNO Staff in General Interest, business, FINANCE, Investing, KTOS, Market, news, Stock, trading, In The News

The products and equipment will be delivered over the next 12 months and will be produced at a secure Kratos facility.

Kratos Defense & Security Solutions has a potential upside of 118.5% based on a current price of $8.85 and an average consensus analyst price target of $19.33.

Kratos Defense & Security Solutions (NASDAQ:KTOS) announced that it received a new $10 million contract award for specialized equipment and products as part of a certain intelligence, surveillance and reconnaissance program.

By FNNO Staff
fnnonline@gmail.com

Impax & GlaxoSmithKline Parkinson's Drug Meets Main Goal in Study

Published on Mon, 08/15/2011 - 13:34
By FNNO Staff in General Interest, business, finance, glaxosmithkline, gsk, impax, investing, ipax, news, parkinson's disease, trading, News Update

Patients treated with the drug had significantly less "off time," or waking time when their medication wore off and the motor symptoms of Parkinson's disease returned.

GlaxoSmithKline has a potential upside of 20.6% based on a current price of $41.93 and an average consensus analyst price target of $50.58.

business, finance, glaxosmithkline, gsk, impax, investing, ipax, news, parkinson's disease, trading

Impax Laboratories and GlaxoSmithKline (NYSE:GSK) said that their extended-release experimental drug for Parkinson's disease met its main goal in a late-stage study. The clinical trial measured the effectiveness of the drug, IPX06

By FNNO Staff
fnnonline@gmail.com

Bank of America To Exit International Credit Card Business

Published on Mon, 08/15/2011 - 12:19
By FNNO Staff in General Interest, bac, business, FINANCE, Investing, Market, news, Stock, trading, In The News

TD Bank Group has agreed to purchase Bank of America's $8.6 billion Canadian credit card portfolio as well as certain other assets and liabilities. The transaction is expected to close in Q4, subject to regulatory approval.

The transaction is expected to have a positive impact on the company's Tier 1 common and tangible common equity and the respective ratios.

Bank of America (NYSE:BAC) has agreed to sell its credit card business in Canada to TD Bank Group (NYSE:TD) and that it plans to exit its credit card businesses in the U.K. and Ireland.

By FNNO Staff
fnnonline@gmail.com

Latest News from FNNO

Next Support Level for DeVry (DV) is $29...

DeVry (NYSE:DV) has opened bearishly below the pivot of $31.05 today and has reached th ...

Next Support Level for Torchmark (TMK) i...

Shares of Torchmark (NYSE:TMK) opened today below their pivot of $64.73 and have alread ...

Next Support Level for Vulcan Materials ...

Vulcan Materials (NYSE:VMC) has opened bearishly below the pivot of $54.18 today and ha ...

Pinnacle West Capital (PNW) Breaks Throu...

Shares of Pinnacle West Capital (NYSE:PNW) have bearishly opened below the pivot of $59 ...

MasterCard (MA) Approaches New Downside ...

MasterCard (NYSE:MA) has opened bearishly below the pivot of $580.38 today and has reac ...

Iron Mountain (IRM) Crosses Pivot Point ...

Shares of Iron Mountain (NYSE:IRM) opened today below their pivot of $38.09 and have al ...

DTE Energy (DTE) Breaks Through Support ...

DTE Energy (NYSE:DTE) has opened bearishly below the pivot of $70.78 today and has reac ...

Northern Trust (NTRS) Breaks Through Sup...

Shares of Northern Trust (NASDAQ:NTRS) have bearishly opened below the pivot of $57.87 ...

Most Popular Video News